{
  "report_rows": [
    {
      "kpi": "Net revenue growth (Q2 2026, reported/ccy-neutral)",
      "prediction": "BEAT",
      "answer": "pred ~+12.3% to $9.16B vs. cons +11.5% to $9.068B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.88 vs. cons $4.77",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Cross-border volume growth, local currency (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~10% vs. cons ~12% (implied by guided 'progressive recovery' base case)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 net revenue growth, currency-neutral",
      "prediction": "UNCHANGED",
      "answer": "guide ~11.5% (high end of low-double-digits) vs. cons ~11.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Cross-border travel growth / recovery pace into Q3",
      "prediction": "LOWER",
      "answer": "guide ~7-8% Q3 travel-linked cross-border growth vs. prior implied recovery to ~11% (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 operating expense growth, currency-neutral",
      "prediction": "UNCHANGED",
      "answer": "guide ~11% vs. cons ~11% (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "Stock rallied ~12% into the print (with a sharp +5% move in the final week of July) pricing a clean beat-and-hold; even a headline EPS/revenue beat is likely accompanied by an admission that the Middle East conflict re-intensified rather than resolved during Q2, pushing out the previously-guided H2 cross-border travel recovery. That implies analysts trim out-quarter cross-border/travel and yield assumptions even as they nudge near-term estimates up for the beat, a net negative revision mix. Combined with an already-elevated valuation after the run-up and Visa's own muted stock reaction despite a beat-and-raise (initial AH dip before flattening), the more likely path is an initial soft/negative reaction that fades further over the week as the market digests delayed cross-border normalization and unchanged-to-cautious FY guidance.",
  "day5_confidence": "LOW"
}